TY - JOUR
T1 - Bridging the gap in heart failure prevention: rationale and design of the Nurse-led Intervention for Less Chronic Heart Failure (NIL-CHF) Study
AU - Carrington, Melinda
AU - Stewart, Simon
AU - Dawson, Wayne Dawson
AU - Bailey, Lia
AU - Wood, Jessica
AU - Lee, Geraldine
AU - Edwards, Trischa
AU - Wong, Chiew
AU - Calderone, Alicia
AU - Jennings, Garry L R
AU - Bergin, Peter
AU - de Courten, Barbora
PY - 2010
Y1 - 2010
N2 - Aims The primary objective of the Nurse-led Intervention for Less Chronic Heart Failure (NIL-CHF) Study is to develop a programme of care that cost-effectively prevents the development of chronic heart failure (CHF).
Methods NIL-CHF is a randomized controlled trial of a hybrid, home- and clinic-based, nurse-led multidisciplinary intervention targeting hospitalized patients at risk of developing CHF. A target of 750 patients aged =45 years will be exposed to usual post-discharge care or the NIL-CHF intervention. The composite primary endpoint is all-cause mortality or CHF-related admission during 3?5 years of follow-up. After 12 months recruitment, 300 eligible patients (40 of target) have been randomized. Overall, 73 are male and the mean age is 65 ? 10 years. The most common antecedents for CHF thus far are hypertension (70 , 95 CI, 64?75 ), coronary artery disease (51 , 95 CI, 31?41 ), and type 2 diabetes (26 , 95 CI, 21?31 ), whereas 76 (95 CI, 69?82 ) of patients have diastolic dysfunction, 29 (95 CI, 23?36 ) left ventricular hypertrophy, 71 (95 CI, 64?78 ) mitral valve dysfunction, and 7 (95 CI, 4?12 ) have a left ventricular ejection fraction =45 .
Conclusion As one of the largest randomized studies of its kind, NIL-CHF will ultimately provide important insights into the potential to prevent CHF via prolonged and intensive disease management.
AB - Aims The primary objective of the Nurse-led Intervention for Less Chronic Heart Failure (NIL-CHF) Study is to develop a programme of care that cost-effectively prevents the development of chronic heart failure (CHF).
Methods NIL-CHF is a randomized controlled trial of a hybrid, home- and clinic-based, nurse-led multidisciplinary intervention targeting hospitalized patients at risk of developing CHF. A target of 750 patients aged =45 years will be exposed to usual post-discharge care or the NIL-CHF intervention. The composite primary endpoint is all-cause mortality or CHF-related admission during 3?5 years of follow-up. After 12 months recruitment, 300 eligible patients (40 of target) have been randomized. Overall, 73 are male and the mean age is 65 ? 10 years. The most common antecedents for CHF thus far are hypertension (70 , 95 CI, 64?75 ), coronary artery disease (51 , 95 CI, 31?41 ), and type 2 diabetes (26 , 95 CI, 21?31 ), whereas 76 (95 CI, 69?82 ) of patients have diastolic dysfunction, 29 (95 CI, 23?36 ) left ventricular hypertrophy, 71 (95 CI, 64?78 ) mitral valve dysfunction, and 7 (95 CI, 4?12 ) have a left ventricular ejection fraction =45 .
Conclusion As one of the largest randomized studies of its kind, NIL-CHF will ultimately provide important insights into the potential to prevent CHF via prolonged and intensive disease management.
UR - http://eurjhf.oxfordjournals.org/content/12/1/82.long
U2 - 10.1093/eurjhf/hfp161
DO - 10.1093/eurjhf/hfp161
M3 - Article
SN - 1388-9842
VL - 12
SP - 82
EP - 88
JO - European Journal of Heart Failure
JF - European Journal of Heart Failure
IS - 1
ER -